Levine Media Group

11/07/2025

Steve Mahoney, CEO of Viridian Therapeutics, Inc., discusses the complexities of thyroid eye disease, the challenges of living with the condition, and why veligrotug has the potential to provide a new alternative for people living with the condition. Global Genes

Steve Mahoney, CEO of Viridian Therapeutics, discusses the complexities of thyroid eye disease, the challenges of living with the condition, and why veligrotug has the potential to provide a new alternative for people living with the condition.

10/07/2025

Craig Lipset, advisor and founder of Clinical Innovation Partners, sits down with Nagaraja Srivatsan to discuss how AI can bring greater predictability to clinical trials, how organizations can effectively adopt the technology, and the importance of fostering a culture of experimentation.

Craig Lipset, advisor and founder of Clinical Innovation Partners, sits down with Nagaraja Srivatsan to discuss how AI can bring greater predictability to cl...

09/07/2025

Niven Narain, CEO of BPGbio, discusses how the company’s platform technology uncovers novel targets, its evolution from its start as Berg, and how the platform continues to provide insight into experimental therapies after they advance to the clinic.

https://thebioreport.podbean.com/e/fueling-ai-drug-development-with-patient-biology/

04/07/2025

Traci Davies and her son Ben Davies both discuss their experiences with primary immunodeficiency, what it’s like to be both a caregiver and patient, and why they have both become patient advocates. Global Genes

Ben Davies and his mother Traci Davies discuss their experiences with primary immunodeficiency, what it's like to be both a caregiver and patient, and why they have both become patient advocates.

27/06/2025

Melanie Kandzierski discusses how she has learned to care for a child with Dravet syndrome, care for herself, and to advocate not only for her child but others with complex medical conditions. Global Genes

Melanie Kandzierski discusses how she has learned to care for a child with Dravet syndrome, care for herself, and to advocate not only for the child but others with complex medical conditions.

26/06/2025

Ariel Katz, co-founder and CEO of H1, sits down with Amar Dravid to discuss the unique dataset behind the company’s platform technology to connect life sciences companies to healthcare providers, the problem it solves for biopharmaceutical companies, and some unexpected ways the platform has been used.

Ariel Katz, co-founder and CEO of H1, sits down with Amar Drawid to discuss how his company’s AI platform allows pharmaceutical companies to identify the rig...

25/06/2025

Steve Ruston, CEO of Persica Pharmaceuticals, discusses the need for new approaches to chronic low back pain, the company’s experimental targeted antibiotic injections, and the need to educate physicians about the role infection can play in the condition.

https://thebioreport.podbean.com/e/a-novel-approach-to-treating-chronic-low-back-pain/

20/06/2025

Patrick Ritschel, CEO of Atsena Therapeutics, discusses the delivery challenges of gene therapies for inherited retinal diseases, how the company’s unique vector technology addresses this, and how it allows for safer and more effective delivery of gene therapies to the retina. Global Genes

One of the challenges of delivering gene therapies to the eye is that once a subretinal injection […]

18/06/2025

Barry Quart, CEO of Connect Biopharma, discusses the unmet need in asthma and COPD, the company’s experimental therapy rademikibart, and the case for a biologic that can address acute exacerbations of these conditions.

https://thebioreport.podbean.com/e/a-biologic-designed-to-treat-acute-exacerbations-of-asthma-and-copd/

13/06/2025

P.J. Brooks, deputy director of the Office of Rare Disease Research at the National Institutes of Health (NIH)'s National Center for Advancing Translational Sciences, discusses the recent treatment of an infant with a bespoke gene editing therapy, how the researchers were able to move from diagnosis to treatment with great speed, and what it would take to scale such an approach. Global Genes

P.J. Brooks, deputy director of the Office of Rare Disease Research at the National Institutes of Health’s National Center for Advancing Translational Sciences, discusses the recent treatment of an infant with a bespoke gene editing therapy, how the researchers were able to move from diagnosis to ...

12/06/2025

Venky Iyer, director of data strategy and automation at Pfizer, sits down with Nagaraja Srivatsan to discuss Iyer’s journey in implementing AI solutions to enhance operational efficiency at Pfizer, the importance of managing change effectively, and the value of AI adoption in improving drug development processes.

Venky Iyer, director of data strategy and automation at Pfizer, sits down with Nagaraja Srivatsan to discuss the transformative role of AI and machine learni...

06/06/2025

Annette Bakker, CEO of the Children's Tumor Foundation, discusses the complexities of neurofibromatosis, the foundation’s role in advancing research and drug development, and what other patient organizations can learn from its strategic approach. Global Genes

Annette Bakker, CEO of the Children's Tumor Foundation, discusses the complexities of a group of rare genetic conditions that cause tumors to grow on nerves throughout the body, the foundation's role in advancing research and drug development, and what other patient organizations can learn from its....